死亡盒酶1通过诱导肝细胞癌中的PD-L1表达来抑制CD8+T细胞抗瘤活性
Junhao Liu1, Ti Yang1,2, Yurong Luo1,2
1Department of Hepatobiliary-Pancreatic & Hernia Surgery, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China.
Cancer science
|January 20, 2024
概括
死亡盒螺旋酶1 (DDX1) 在肝细胞癌 (HCC) 中过度表达,通过增加PD-L1表达来促进免疫逃生. 这阻碍了CD8+ T细胞的功能,表明DDX1作为免疫检查点抑制剂治疗的生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 对目前的治疗反应不佳,包括免疫检查点抑制剂 (ICI).
- 瘤的免疫逃逸,特别是通过编程细胞死亡配体1 (PD-L1),是限制ICI疗效的关键因素.
- 在HCC中调节PD-L1表达和免疫逃逸的机制需要进一步阐明.
研究的目的:
- 研究DEAD-box酶1 (DDX1) 在HCC进展和免疫逃避中的作用.
- 确定DDX1对PD-L1表达和CD8+T细胞功能在HCC微环境中的影响.
- 评估DDX1作为HCCICI治疗的潜在预测生物标志物.
主要方法:
- 对HCC组织中DDX1表达的分析以及与患者预后和CD8+T细胞透的相关性.
- 使用HCC细胞系进行体外研究,以评估DDX1过度表达对干扰素 (IFN-γ) 中介的PD-L1诱导的影响.
- 评估DDX1对CD8+T细胞功能的影响,包括细胞因子的产生 (IFN-γ,granzyme B) 和细胞毒性活动,体外和体内.
主要成果:
- 发现DDX1在HCC组织中过度表达,与患者预后较差相关.
- DDX1表达与瘤微环境中CD8+T细胞的频率呈负相关性.
- 过度表达DDX1显著增强IFN-γ诱导的PD-L1表达在HCC细胞.
- 过度表达DDX1抑制了CD8+T细胞中的IFN-γ和B大酶的产生,损害了它们的细胞毒性功能,无论是体外还是体内.
结论:
- 在HCC中,DDX1在建立免疫抑制微环境方面发挥着至关重要的作用.
- 通过调节PD-L1并抑制抗瘤T细胞反应,DDX1有助于瘤免疫逃生.
- 在肝细胞癌中,DDX1代表了免疫检查点抑制剂疗法在肝细胞癌中疗效的潜在预测生物标志物.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


